Filing Details
- Accession Number:
- 0001179110-11-009431
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-08 18:59:26
- Reporting Period:
- 2011-06-07
- Filing Date:
- 2011-06-08
- Accepted Time:
- 2011-06-08 18:59:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1347405 | Robert Bowen | C/O Abiomed, Inc 22 Cherry Hill Dr Danvers MA 01923 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Disposition | 2011-06-07 | 3,648 | $17.12 | 66,605 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $15.92 | 2009-12-22 | 2018-12-22 | 100,000 | 100,000 | Direct |
| Common Stock | Stock Option (right to buy) | $5.86 | 2010-05-28 | 2019-05-28 | 60,000 | 60,000 | Direct |
| Common Stock | Stock Option (right to buy) | $5.86 | 2010-03-31 | 2019-05-28 | 30,000 | 30,000 | Direct |
| Common Stock | Stock Option (right to buy) | $10.03 | 2011-06-03 | 2020-06-03 | 30,000 | 30,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2018-12-22 | 100,000 | 100,000 | Direct |
| 2019-05-28 | 60,000 | 60,000 | Direct |
| 2019-05-28 | 30,000 | 30,000 | Direct |
| 2020-06-03 | 30,000 | 30,000 | Direct |
Footnotes
- Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
- These options become exerciseable in annual 25% increments, commencing on the date set forth in Table II, Column 6.
- These options became exerciseable in full on March 31, 2010.
- The price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $16.93 and $17.21. Detailed information regarding this number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- Includes 10,000 shares represented by a performance share award for restricted stock units pursuant to which one third of the shares will be issued to the reporting person on each of May 26, 2012, May 26, 2013 and May 26, 2014, so long as he continues to be employed by the issuer on the vesting dates.
- Sale of common stock pursuant to reporting owner's 10(b)5-1 plan.
Billionaire Hedge Funds
